Researchers evaluated the antibody response among 84 pregnant women, 31 women who were breastfeeding and 16 nonpregnant women who received Pfizer or Moderna’s mRNA vaccines. Participants were sampled after their first or second doses, with a subset sampled after each of the doses.
Pregnant and breastfeeding women had fewer antibodies than other women of the same age after their first dose, the findings showed. Those antibodies were also less effective at kickstarting other parts of the immune system to ward off the virus.
Two to six weeks after the second dose, however, pregnant and breastfeeding women had about the same level of antibodies of their nonpregnant counterparts.
“The authors found that two doses of vaccine were required for pregnant or lactating women to achieve immune responses comparable to that of nonpregnant women,” the Oct. 19 study said.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
